Home
Conditions
Leukemia

Clinical trial condition

Leukemia

Explore clinical trials studying Leukemia. Study availability and eligibility vary by location and protocol.

4,408 public trials 1,033 recruiting studies

Refine in advanced search Browse all conditions

Leukemia trial results

Active, Not Recruiting

Cardiovascular Reserve Evaluation in Survivors of Transplant, CREST Study

NCT04537871

Conditions: Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia, Blood Protein Disorders, +32 more
Locations: City of Hope Medical Center Duarte, California, United States

View Trial Details

Active, Not Recruiting

Venetoclax Combined With ATRA and ATO in Hyperleukocytic Acute Promyelocytic Leukemia

NCT07187505

Conditions: Acute Promyelocytic Leukemia (APL), Hematologic Diseases, Hemic and Lymphatic Diseases, +6 more
Locations: Department of Hematology, The First Affiliated Hospital of Anhui Medical University, 218 Jixi Road Hefei, Anhui, China

View Trial Details

Active, Not Recruiting

Trial Treating Relapsed Acute Lymphoblastic Leukemia With Venetoclax and Navitoclax

NCT05192889

Conditions: Hematologic Diseases, Hemic and Lymphatic Diseases, Immune System Diseases, +10 more
Locations: Memorial Sloan Kettering Cancer Center New York, United States

St. Jude Children's Research Hospital Memphis, Tennessee, United States

View Trial Details

Active, Not Recruiting

Chimeric Antigen Receptor T-cells for The Treatment of AML Expressing CLL-1 Antigen

NCT04219163

Conditions: Acute Myeloid Leukemia, Hematologic Diseases, Hemic and Lymphatic Diseases, +5 more
Locations: Texas Children's Hospital Houston, Texas, United States

View Trial Details

Active, Not Recruiting

2nd or 3rd TKI-stop After 2 Years Nilotinib Pre-treatment in CML-patients

NCT02917720

Conditions: Bone Marrow Diseases, Chronic Disease, Chronic Myeloid Leukemia, +11 more
Locations: Universitätsklinikum Freiburg Freiburg im Breisgau, Baden-Wurttemberg, Germany

Universitätsmedizin Mannheim Mannheim, Baden-Wurttemberg, Germany

Klinikum rechts der Isar München, Bavaria, Germany

Medizinische Hochschule Hannover Hannover, North Rhine-Westphalia, Germany

View all 15 locations

View Trial Details

Active, Not Recruiting

Bosutinib in Pediatric Patients With Newly Diagnosed Chronic Phase or Resistant/Intolerant Ph + Chronic Myeloid Leukemia

NCT04258943

Conditions: Accelerated Phase Chronic Myelogenous Leukemia, Blast Crisis, Blastic Phase Chronic Myelogenous Leukemia, +20 more
Locations: Children's Hospital of Alabama Birmingham, Alabama, United States

Phoenix Childrens Hospital Phoenix, Arizona, United States

Arkansas Children's Hospital Little Rock, Arkansas, United States

Kaiser Permanente Downey Medical Center Downey, California, United States

View all 59 locations

View Trial Details

Active, Not Recruiting

Genetically Modified T-cell Immunotherapy in Treating Patients With Relapsed/Refractory Acute Myeloid Leukemia and Persistent/Recurrent Blastic Plasmacytoid Dendritic Cell Neoplasm

NCT02159495

Conditions: Acute Biphenotypic Leukemia, Acute Myeloid Leukemia, Adult Acute Lymphoblastic Leukemia, +35 more
Locations: City of Hope Medical Center Duarte, California, United States

View Trial Details

Active, Not Recruiting

A French Protocol for the Treatment of Acute Lymphoblastic Leukemia (ALL) in Children and Adolescents

NCT02716233

Conditions: Acute Lymphoblastic Leukemia, Hematologic Diseases, Hemic and Lymphatic Diseases, +9 more
Locations: CHU Amiens, France

CHU Angers, France

CHRU Besançon, France

CHU Bordeaux, France

View all 28 locations

View Trial Details

Active, Not Recruiting

Modified Immune Cells (CD19/CD20 CAR-T Cells) in Treating Patients With Recurrent or Refractory B-Cell Lymphoma or Chronic Lymphocytic Leukemia

NCT04007029

Conditions: CD19 Positive, CD20 Positive, Chronic Disease, +33 more
Locations: UCLA / Jonsson Comprehensive Cancer Center Los Angeles, California, United States

View Trial Details

Active, Not Recruiting

A Post-treatment Program to Identify and Manage Complications Related to Oncology or Hematology Treatments in Cancer Survivors.

NCT04671693

Conditions: Acute Myeloid Leukemia, Ewing's Sarcoma, Hematologic Diseases, +24 more
Locations: Centre Leon Berard Lyon, France

View Trial Details

Leukemia

Leukemia trial results

Related conditions